Home › Anaplastic Large-Cell Lymphoma › Massachusetts › Boston
Anaplastic Large-Cell Lymphoma clinical trials in Boston, MA
3 studies for Anaplastic Large-Cell Lymphoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 1/2
- Dana Farber Cancer Institute., Boston
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Massachusetts General Hospital, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Anaplastic Large-Cell Lymphoma trials in other cities
- Atlanta, GA4 studies
- St. Louis, MO4 studies
- Houston, TX4 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Philadelphia, PA3 studies
- New York City, NY3 studies
- Baldwin Park, CA3 studies
- Seattle, WA3 studies
- Columbus, OH3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.